Skip to content
MedsAcross

Medicine

Olmesartan 20 mg tablet

Olmesartan · Oral
Available on requestPrescription onlyUS FDAGeneric name

Olmesartan 20 mg tablet is a generic prescription medicine for oral use, made by 28 labelers, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians.

Availability

Available on request

Export supply from India to licensed buyers

Typical lead time

On request

Counted from payment and complete documents

Shipping

Ambient

Store at 20°C to 25°C (68°F to 77°F).

Key facts

Active ingredient (INN)
Olmesartan
Brand
Sold under the generic name
Strength
20 mg
Dosage form
Tablet
Route
Oral
Packs
100 tablets, 30 tablets, 90 tablets and 117 more
Manufacturers
Alembic PharmaceuticalsIndiaAscend LaboratoriesIndiaAurobindo PharmaIndiaJubilant Cadista PharmaceuticalsIndiaGlenmark PharmaceuticalsIndiaAccord HealthcareIndiaCadila PharmaceuticalsIndiaCamber PharmaceuticalsIndiaLifestar PharmaIndia28 labelers on the register
Origin register
US FDA, United States
Storage
Store at 20°C to 25°C (68°F to 77°F).
Cold chain
Not required on record
Prescription status
Prescription only
Controlled substance
Not recorded as controlled
ATC code
C09CA08 Olmesartan
HS code (indicative)
3004.90Indicative only. Your customs broker confirms the final tariff code.
Marketing category
marketed
Marketed since
1 April 2016
Identifiers
RxCUI 349401, 349405, 349373DailyMed set ID b57e47a5-43e0-d1c5-e053-2a95a90a2b07, 98f930d5-f7c2-4870-92b4-0ad37ce45797, 26065167-37c9-4e95-aa2c-3005b6805a52 +37NDC 72189-137, 82009-074, 50090-3656 +37Application ANDA207662, ANDA204798, ANDA206763 +12

Record updated 12 November 2026

Documents available

Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.

No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.

Packs

A sample of 40 packs from 28 labelers. The register lists 120 packs for this generic presentation, and we confirm the exact pack on the quote.

PackCodeLabelerMarketed since
100 tablet, film coated in 1 carton46708-132-10Alembic PharmaceuticalsIndia24 April 2017
30 tablet, film coated in 1 bottle46708-132-30Alembic PharmaceuticalsIndia24 April 2017
90 tablet, film coated in 1 bottle46708-132-90Alembic PharmaceuticalsIndia24 April 2017
1000 tablet, film coated in 1 bottle46708-132-91Alembic PharmaceuticalsIndia24 April 2017
100 tablet, film coated in 1 carton62332-132-10Alembic PharmaceuticalsIndia24 April 2017
30 tablet, film coated in 1 bottle62332-132-30Alembic PharmaceuticalsIndia24 April 2017
90 tablet, film coated in 1 bottle62332-132-90Alembic PharmaceuticalsIndia24 April 2017
1000 tablet, film coated in 1 bottle62332-132-91Alembic PharmaceuticalsIndia24 April 2017
30 tablet, film coated in 1 bottle, plastic16729-321-10Accord HealthcareIndia27 April 2017
90 tablet, film coated in 1 bottle, plastic16729-321-15Accord HealthcareIndia27 April 2017
1000 tablet, film coated in 1 bottle, plastic16729-321-17Accord HealthcareIndia27 April 2017
500 tablet, coated in 1 bottle67877-446-05Ascend LaboratoriesIndia24 April 2017
1000 tablet, coated in 1 bottle67877-446-10Ascend LaboratoriesIndia24 April 2017
30 tablet, coated in 1 bottle67877-446-30Ascend LaboratoriesIndia24 April 2017
1 blister pack in 1 carton / 10 tablet, coated in 1 blister pack67877-446-33Ascend LaboratoriesIndia24 April 2017
10 blister pack in 1 carton / 10 tablet, coated in 1 blister pack67877-446-38Ascend LaboratoriesIndia24 April 2017
5 blister pack in 1 carton / 10 tablet, coated in 1 blister pack67877-446-74Ascend LaboratoriesIndia24 April 2017
3 blister pack in 1 carton / 10 tablet, coated in 1 blister pack67877-446-84Ascend LaboratoriesIndia24 April 2017
90 tablet, coated in 1 bottle67877-446-90Ascend LaboratoriesIndia24 April 2017
100 tablet, film coated in 1 bottle65862-742-01Aurobindo PharmaIndia24 April 2017
500 tablet, film coated in 1 bottle65862-742-05Aurobindo PharmaIndia24 April 2017
30 tablet, film coated in 1 bottle65862-742-30Aurobindo PharmaIndia24 April 2017
10 blister pack in 1 carton / 10 tablet, film coated in 1 blister pack65862-742-78Aurobindo PharmaIndia24 April 2017
90 tablet, film coated in 1 bottle65862-742-90Aurobindo PharmaIndia24 April 2017
1000 tablet, film coated in 1 bottle65862-742-99Aurobindo PharmaIndia24 April 2017
30 tablet, coated in 1 bottle71209-080-01Cadila PharmaceuticalsIndia1 January 2025
90 tablet, coated in 1 bottle71209-080-04Cadila PharmaceuticalsIndia1 January 2025
500 tablet, coated in 1 bottle71209-080-10Cadila PharmaceuticalsIndia1 January 2025
30 tablet, film coated in 1 bottle31722-853-30Camber PharmaceuticalsIndia23 May 2025
90 tablet, film coated in 1 bottle31722-853-90Camber PharmaceuticalsIndia23 May 2025
1000 tablet, film coated in 1 bottle68462-437-10Glenmark PharmaceuticalsIndia25 May 2017
10 blister pack in 1 carton / 10 tablet, film coated in 1 blister pack68462-437-11Glenmark PharmaceuticalsIndia25 May 2017
30 tablet, film coated in 1 bottle68462-437-30Glenmark PharmaceuticalsIndia25 May 2017
90 tablet, film coated in 1 bottle68462-437-90Glenmark PharmaceuticalsIndia25 May 2017
100 tablet, film coated in 1 bottle, plastic59746-465-01Jubilant Cadista PharmacuticalsIndia24 April 2017
1000 tablet, film coated in 1 bottle, plastic59746-465-10Jubilant Cadista PharmacuticalsIndia24 April 2017
30 tablet, film coated in 1 bottle, plastic59746-465-30Jubilant Cadista PharmacuticalsIndia24 April 2017
3 blister pack in 1 carton / 10 tablet, film coated in 1 blister pack59746-465-32Jubilant Cadista PharmacuticalsIndia24 April 2017
90 tablet, film coated in 1 bottle, plastic59746-465-90Jubilant Cadista PharmacuticalsIndia24 April 2017
30 tablet in 1 bottle70756-809-30Lifestar PharmaIndia1 May 2020

Status by register

Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.

RegisterStatusSource
US FDAListed, marketedSource record for this pageChecked 12 November 2026
US FDAFirst approved 25 April 2002Drugs@FDA
EU (EMA)Not recorded—
India (CDSCO)Not yet confirmed against CDSCO approval lists—
United StatesRegisteredUS FDA (NDC directory, openFDA)Checked 12 November 2026

Import route

Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.

Import guides are available for 25 countries. Pick one to see its route summary.

BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides

Alternatives

Other makers and brands of Olmesartan 20 mg tablet.

Compare 1

Other strengths and forms of Olmesartan

Clinical summary

Olmesartan is an angiotensin 2 receptor blocker indicated for the treatment of hypertension in adults and children six years of age and older, to lower blood pressure. It is available as tablets for oral use. MedsAcross supplies Olmesartan for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.

Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review

Read about Olmesartan

For healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.

Data sources

Need Olmesartan 20 mg tablet for your hospital or patient?

Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.